All Publications


  • Palliative Care Service Utilization and Advance Care Planning for Adult Glioblastoma Patients: A Systematic Review Cancers Wu, A., Ruiz Col√≥n, G., Aslakson, R., Pollom, E., Patel, C. 2021; 13 (12)

    Abstract

    Glioblastoma (GBM) has a median overall survival of 16-21 months. As patients with GBM suffer concurrently from terminal cancer and a disease with progressive neurocognitive decline, advance care planning (ACP) and palliative care (PC) are critical. We conducted a systematic review exploring published literature on the prevalence of ACP, end-of-life (EOL) services utilization (including PC services), and experiences among adults with GBM. We searched from database inception until 20 December 2020. Preferred reporting items for systematic reviews guidelines were followed. Included studies were assessed for quality using the Newcastle-Ottawa Scale. The 16 articles were all nonrandomized studies conducted in six countries with all but two published in 2014 or later. ACP documentation varied from 4-55%, PC referral was pursued in 39-40% of cases, and hospice referrals were made for 66-76% of patients. Hospitalizations frequently occurred at the EOL with 20-56% of patients spending over 25% of their overall survival time hospitalized. Many GBM patients do not pursue ACP or have access to PC. There is a dearth of focused and high-quality studies on ACP, PC, and hospice use among adults with GBM. Prospective studies that address these and additional aspects related to EOL care, such as healthcare costs and inpatient supportive care needs, are needed.

    View details for DOI 10.3390/cancers13122867

    View details for PubMedCentralID PMC8228109

  • Health Disparities in Germline Genetic Testing for Cancer Susceptibility Current Breast Cancer Reports Parikh, D. A., Dickerson, J. C., Kurian, A. W. 2020